Subcutaneous immunoglobulin as first-line therapy in treatment-naive patients with chronic inflammatory demyelinating polyneuropathy: randomized controlled trial study

Autor: Johannes Jakobsen, Henning Andersen, Danish Cidp, Ingelise Christiansen, Niels Kjær Olsen, Lars Høj Markvardsen, Søren H. Sindrup

Publikováno v: Markvardsen, L H, Sindrup, S H, Christiansen, I, Olsen, N K, Jakobsen, J, Andersen, H & Danish CIDP and MMN Study Group 2017, ' Subcutaneous immunoglobulin as first-line therapy in treatment-naive patients with chronic inflammatory demyelinating polyneuropathy : randomized controlled trial study ', European Journal of Neurology, vol. 24, no. 2, pp. 412-418 . https://doi.org/10.1111/ene.13218
Markvardsen, L H, Sindrup, S H, Christiansen, I, Olsen, N K, Jakobsen, J & Andersen, H 2017, ' Subcutaneous immunoglobulin as first-line therapy in treatment-naive patients with chronic inflammatory demyelinating polyneuropathy: randomized controlled trial study. ', European Journal of Neurology, vol. 24, no. 2, pp. 412-418 . https://doi.org/10.1111/ene.13218
Markvardsen, L H, Sindrup, S H, Christiansen, I, Olsen, N K, Jakobsen, J, Andersen, H & On behalf of The Danish CIDP and MMN Study Group 2017, ' Subcutaneous immunoglobulin as first-line therapy in treatment-naive patients with chronic inflammatory demyelinating polyneuropathy : randomized controlled trial study ', European Journal of Neurology, vol. 24, no. 2, pp. 412-418 . https://doi.org/10.1111/ene.13218

BACKGROUND AND PURPOSE: Subcutaneous immunoglobulin (SCIG) is effective as maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP). We investigated whether multiple subcutaneous infusions are as effective as conventional the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b1c9fca944122c2bb13a8e50f0295e7
https://doi.org/10.1111/ene.13218

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: A Historical Perspective.

Autor: Cocito, Dario¹ (AUTHOR) dariococito@yahoo.it, Peci, Erdita¹ (AUTHOR), Torrieri, Maria Claudia² (AUTHOR) mariaclaudia.torrieri@gmail.com, Clerico, Marinella³ (AUTHOR) marinella.clerico@unito.it

Publikováno v: Journal of Clinical Medicine. Nov2023, Vol. 12 Issue 22, p6961. 10p.

Maintenance IV immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy.

Autor: Kuitwaard, Krista^1,2 k.kuitwaard@erasmusmc.nl, Fokkink, Willem‐Jan R.^1,3, Brusse, Esther¹, Vrancken, Alexander F. J. E.⁴, Eftimov, Filip⁵, Notermans, Nicolette C.⁴, van der Kooi, Anneke J.⁵, Merkies, Ingemar S. J.^6,7, Jacobs, Bart C.^1,3, van Doorn, Pieter A.¹

Publikováno v: Journal of the Peripheral Nervous System. Dec2017, Vol. 22 Issue 4, p425-432. 8p.

Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease.

Autor: Chen, John J., Huda, Saif, Hacohen, Yael, Levy, Michael, Lotan, Itay, Wilf-Yarkoni, Adi, Stiebel-Kalish, Hadas, Hellmann, Mark A., Sotirchos, Elias S., Henderson, Amanda D., Pittock, Sean J., Bhatti, M. Tariq, Eggenberger, Eric R., Di Nome, Marie, Kim, Ho Jin, Kim, Su-Hyun, Saiz, Albert, Paul, Friedemann, Dale, Russell C., Ramanathan, Sudarshini

Publikováno v: JAMA Neurology; May2022, Vol. 79 Issue 5, p518-525, 8p